L. Michael Glodé, MD, on Prostate Cancer: Results From SWOG S9921

2017 Genitourinary Cancers Symposium
Tweet this page

L. Michael Glodé, MD, of the University of Colorado Cancer Center, discusses study findings on adjuvant androgen deprivation vs mitoxantrone plus prednisone plus ADT in high-risk prostate cancer patients following radical prostatectomy. (Abstract 2)

Advertisement

Advertisement



Advertisement

click me